BioSpace News Archive

Beckman Coulter, a global leader in clinical diagnostics, today announced it will debut its hematology analyzer and slidemaker stainer connected to Scopio Labs’ digital morphology platform for end-to-end digitization with artificial intelligence-assisted peripheral blood smear analysis at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo.

Inozyme Pharma, Inc. today announced that it will host a conference call to provide an update on the Company’s ENPP1 Deficiency program on July 26, 2023, at 8am ET.

Schrödinger will report its second quarter 2023 financial results on Wednesday, August 2, 2023, after the financial markets close.

Visiox Pharma, Inc. today announced it has entered into a definitive agreement with Santen Pharmaceutical Co., Ltd to license OMLONTI ®.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 12th International AIDS Society Conference on HIV Science (IAS 2023), taking place in Brisbane, Australia, and virtually, from July 23-26, 2023.

Welltower® Inc. (NYSE: WELL) today announced it will release second quarter 2023 financial results after the close of trading on the New York Stock Exchange on Monday, July 31, 2023.

Verantos today announced two peer-reviewed publications on high-quality real-world data for migraine.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that full results from the Phase 3, double-blind, placebo-controlled AURORA 2 extension study were published online in Arthritis & Rheumatology, the official peer-reviewed journal of the American College of Rheumatology.

Medical device maker CEFALY Technology announced that two post-hoc analyses of the TEAM (a phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine) study were presented as posters at the American Headache Society’s 65th Annual Scientific Meeting June 15-18 in Austin, Texas.

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first quarter financial results at 9:00 a.m. ET on August 2, 2023.